來(lái)源:市場(chǎng)資訊
(來(lái)源:一品紅藥業(yè)集團(tuán)股份有限公司)
![]()
獻(xiàn):
1.Tang YM, Zhang L, Zhu SZ, et al. Gout in China, 1990-2017: the Global Burden of Disease Study 2017[J]. Public Health, 2021, 191:33-38.
2.第一財(cái)經(jīng)商業(yè)數(shù)據(jù)中心(CBNData). 2021中國(guó)高尿酸血癥及痛風(fēng)趨勢(shì)白皮書[R]. 2021.
3.中華醫(yī)學(xué)會(huì)內(nèi)分泌學(xué)分會(huì).中國(guó)高尿酸血癥與痛風(fēng)診療指南(2019) [J]. 中華內(nèi)分泌代謝雜志, 2020, 36(01):1-13.
4.2019 ACR/ARP Annual Meeting Abstract NO: 1224
5.ACR Convergence 2020 Abstract NO: 0675
6.ACR Convergence 2021 Abstract NO: 1570,Abstract NO: L15
7.ACR Convergence 2023 Abstract NO: 1110,Abstract NO: 0244
8.POS0268?,Keenan, R. et al.Annals of the Rheumatic Diseases, Volume 83, 409
聲明:
1.本資訊旨在分享學(xué)術(shù)前沿動(dòng)態(tài),僅供醫(yī)療衛(wèi)生專業(yè)人士基于學(xué)術(shù)目的參閱,非廣告用途。其中涉及的藥品信息僅供參考,不作為臨床用藥指導(dǎo)。
2.若您想了解具體疾病診療信息,請(qǐng)遵從醫(yī)療衛(wèi)生專業(yè)人士的意見(jiàn)與指導(dǎo)。
特別聲明:以上內(nèi)容(如有圖片或視頻亦包括在內(nèi))為自媒體平臺(tái)“網(wǎng)易號(hào)”用戶上傳并發(fā)布,本平臺(tái)僅提供信息存儲(chǔ)服務(wù)。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.